Universe Pharmaceuticals INCUPC
Price$4.30

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →

No analyst estimates are published for this company.

Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.

Monitoring Framework
Key Performance Indicators
Annual Revenue Annually17.9M
Net Income (Loss) Annually-3.7M
Gross Profit Margin Annually3,528.0%
Watch Items
  • Nasdaq Listing Compliance and Delisting RisksTrigger: Minimum bid price below $1.00 or delayed financial filingsAction: Monitor SEC filings and potential reverse stock splits or share consolidations to maintain listing requirements.
  • Concentration of Voting Power under Dual-Class Share StructureTrigger: CEO voting power changes from current ~75%Action: Evaluate corporate governance risks and impact of dual-class structure implemented on February 13, 2026.
Sign in / Sign up to read more

Research as of 20 Jun 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.